| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |